Millennium Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Millennium Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-852,040	Closed	-$28.8M	–	7639
2021 Q2	$28.8M	Buy	+852,040	New	+$21.7M	0.02%	922
2021 Q1	–	Sell	-322,684	Closed	-$9.78M	–	6787
2020 Q4	$9.29M	Sell	322,684 -136,602	-30%	-$3.44M	0.01%	1813
2020 Q3	$9.3K	Buy	459,286 +277,785	+153%	+$6.78M	0.01%	1327
2020 Q2	$5.45M	Sell	181,501 -234,467	-56%	-$8.45M	0.01%	1689
2020 Q1	$13.1M	Sell	415,968 -152,831	-27%	-$5.31M	0.03%	676
2019 Q4	$26.8M	Buy	+568,799	New	+$16.4M	0.03%	668
2018 Q4	–	Sell	-23,797	Closed	-$160K	–	4371
2018 Q3	$160K	Buy	+23,797	New	+$227K	﹤0.01%	3677

Millennium Management's CNST Position: Q3 2021 in Review

Millennium Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 852,040 shares — an estimated $28.8M sold.

Millennium Management first reported a position in CNST in Q3 2018 and held it in 7 quarters. The position peaked at $28.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Millennium Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Millennium Management sold 852,040 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $28.8M.
Millennium Management first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2018 and held it in 7 quarters.
Millennium Management's Constellation Pharmaceuticals, Inc. position peaked at $28.8M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.